Investment analysts at StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 2.5 % EGRX opened at $3.43 on Wednesday. The company’s 50-day moving […]
Analysts at StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Price Performance Eagle Pharmaceuticals stock opened at $3.81 on Tuesday. Eagle Pharmaceuticals has a one year low of […]
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.47 and traded as low as $4.57. Eagle Pharmaceuticals shares last traded at $4.69, with a volume of 161,336 shares changing hands. Eagle Pharmaceuticals Stock Up 2.1 […]
DGS Capital Management LLC purchased a new position in shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,419 shares of the specialty pharmaceutical company’s stock, valued at approximately $60,000. DGS Capital […]
Brandes Investment Partners LP boosted its holdings in shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Free Report) by 34.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,134,363 shares of the specialty pharmaceutical company’s stock after buying an additional 293,276 shares during the period. […]